E. S. Kim et al. / Tetrahedron Letters 50 (2009) 5098–5101
5101
and extracted with CH2Cl2 (50 mL). Drying with MgSO4 and removal of solvent
provided compound 4a as a white solid in a crude state, 691 mg (97%). To the
crude 4a (534 mg, 1.5 mmol) in CH2Cl2 (4 mL) was added TFAA (630 mg,
3.0 mmol) and stirred at room temperature (20–25 °C) for 2 h. After the usual
aqueous extractive workup and column chromatographic purification process
(hexanes/ether, 10:1) compound 5a was isolated as a white solid, 461 mg (91%).
Compound 5a (338 mg, 1.0 mmol) in CH3CN (3 mL) was treated with DBU (76 mg,
0.5 mmol) and stirred at room temperature (20–25 °C) for 1 h. After the usual
aqueous extractive workup and column chromatographic purification process
(hexanes/CH2Cl2/ether, 15:1:1) compound 7a was isolated as a white solid,
tuted benzenes, naphthalene, and phenanthrene from the prepared
-pyrones by using DDQ oxidation and/or Diels–Alder reaction
with DMAD.
a
Acknowledgments
This work was supported by the Korea Research Foundation
Grant funded by the Korean Government (MOEHRD, KRF-2008-
313-C00487). Spectroscopic data were obtained from the Korea Ba-
sic Science Institute, Gwangju branch.
294 mg (87%).
A mixture of 7a (169 mg, 0.5 mmol) and DMAD (213 mg,
1.5 mmol) in p-xylene (1 mL) was heated to 180 °C in a sealed tube for 25 h.
After removal of solvent and column chromatographic purification process
(hexanes/CH2Cl2/ether, 15:1:1) compound 8a was isolated as a white solid,
214 mg (98%). Other compounds were synthesized analogously and
representative spectroscopic data of 7a, 7b, 7d, 7f, 6f, 8a, 8d, 9d, and 9h are as
follows. Known compounds, 7c,2a 7e,2a 8f,6a and 103a were identified by
comparison with the reported data.
References and notes
1. For the general review on Baylis–Hillman reaction, see: (a) Basavaiah, D.; Rao, A.
J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811–891; (b) Singh, V.; Batra, S.
Tetrahedron 2008, 64, 4511–4574; (c) Declerck, V.; Martinez, J.; Lamaty, F. Chem.
Rev. 2009, 109, 1–48; (d) Ciganek, E.. In Organic Reactions; Paquette, L. A., Ed.; John
Wiley & Sons: New York, 1997; Vol. 51, pp 201–350; (e) Basavaiah, D.; Rao, P. D.;
Hyma, R. S. Tetrahedron 1996, 52, 8001–8062; (f) Drewes, S. E.; Roos, G. H. P.
Tetrahedron 1988, 44, 4653–4670; (g) Kim, J. N.; Lee, K. Y. Curr. Org. Chem. 2002, 6,
627–645; (h) Lee, K. Y.; Gowrisankar, S.; Kim, J. N. Bull. Korean Chem. Soc. 2005, 26,
1481–1490; (i) Langer, P. Angew. Chem., Int. Ed. 2000, 39, 3049–3052; (j) Krishna,
P. R.; Sachwani, R.; Reddy, P. S. Synlett 2008, 2897–2912.
Compound 7a: 87%; white solid, mp 176–178 °C; IR (KBr) 1712, 1540, 1489 cmÀ1
;
1H NMR (CDCl3, 300 MHz) d 1.98 (s, 3H), 6.81–6.92 (m, 4H), 6.98–7.08 (m, 3H),
7.12–7.29 (m, 8H); 13C NMR (CDCl3, 75 MHz) d 14.63, 119.37, 121.13, 127.05,
127.53, 127.81, 127.91, 128.00, 128.27, 129.14 (2C), 131.19, 132.73, 135.15,
136.57, 154.59, 154.61, 163.46; ESIMS m/z 339 (M++1). Anal. Calcd for C24H18O2:
C, 85.18; H, 5.36. Found: C, 85.01; H, 5.49.
Compound 7b: 74%; pale yellow solid, mp 202–204 °C; IR (KBr) 1705, 1606,
1504 cmÀ1 1H NMR (CDCl3, 300 MHz) d 1.95 (s, 3H), 3.69 (s, 3H), 3.75 (s, 3H),
;
6.55–6.60 (m, 2H), 6.67–6.75 (m, 4H), 6.87–6.91 (m, 2H), 7.14–7.26 (m, 5H); 13C
NMR (CDCl3, 75 MHz) d 14.57, 55.00, 55.17, 113.28, 113.56, 117.96, 120.13,
125.29, 127.41, 127.61, 127.93, 128.25, 130.62, 132.26, 136.89, 154.62, 155.19,
158.38, 160.02, 163.66; ESIMS m/z 399 (M++1). Anal. Calcd for C26H22O4: C, 78.37;
H, 5.57. Found: C, 78.62; H, 5.44.
2. For the synthesis of
a-pyrone derivatives, see: (a) Kuninobu, Y.; Kawata, A.;
Nishi, M.; Takata, H.; Takai, K. Chem. Commun. 2008, 6360–6362; (b) Yao, T.;
Larock, R. C. J. Org. Chem. 2003, 68, 5936–5942; (c) Larock, R. C.; Doty, M. J.; Han,
X. J. Org. Chem. 1999, 64, 8770–8779; (d) Larock, R. C.; Han, X.; Doty, M. J.
Tetrahedron Lett. 1998, 39, 5713–5716; (e) Bellina, F.; Biagetti, M.; Carpita, A.;
Rossi, R. Tetrahedron 2001, 57, 2857–2870; (f) Biagetti, M.; Bellina, F.; Carpita,
A.; Stabile, P.; Rossi, R. Tetrahedron 2002, 58, 5023–5038; (g) Zhu, X.-F.;
Schaffner, A.-P.; Li, R. C.; Kwon, O. Org. Lett. 2005, 7, 2977–2980; (h) Ma, S.; Yu,
S.; Yin, S. J. Org. Chem. 2003, 68, 8996–9002; (i) Ma, S.; Yin, S.; Li, L.; Tao, F. Org.
Lett. 2002, 4, 505–507.
Compound 7d: 74%; yellow solid, mp 172–174 °C; IR (KBr) 1697, 1629,
1530 cmÀ1 1H NMR (CDCl3, 300 MHz) d 1.92 (s, 3H), 2.31 (t, J = 7.8 Hz, 2H),
;
2.78 (t, J = 7.8 Hz, 2H), 7.12–7.18 (m, 3H), 7.25–7.34 (m, 2H), 7.39–7.51 (m, 3H),
7.88–7.91 (m, 1H); 13C NMR (CDCl3, 75 MHz) d 14.50, 23.39, 27.49, 112.64,
120.98, 123.04, 127.04, 127.47, 127.56, 128.24, 128.37, 128.77, 129.65, 136.14,
136.69, 151.64, 153.90, 163.40; ESIMS m/z 289 (M++1). Anal. Calcd for C20H16O2:
C, 83.31; H, 5.59. Found: C, 83.24; H, 5.76.
3. For the synthesis of coumarin and isocoumarin derivatives, see: (a) Park, K. H.;
Jung, I. G.; Chung, Y. K. Synlett 2004, 2541–2544; (b) Kadnikov, D. V.; Larock, R.
C. J. Org. Chem. 2003, 68, 9423–9432; (c) Kadnikov, D. V.; Larock, R. C. Org. Lett.
2000, 2, 3643–3646.
Compound 7f: 56%;colorless oil; IR (film) 1712, 1642, 1558 cmÀ1;1H NMR (CDCl3,
300 MHz) d 1.56–1.64 (m, 2H), 1.66–1.80 (m, 2H), 1.82 (s, 3H), 1.93–1.97 (m, 2H),
2.55–2.59 (m, 2H), 7.06–7.10 (m, 2H), 7.35–7.47 (m, 3H); 13C NMR (CDCl3,
75 MHz) d 13.95, 21.68, 22.29, 25.18, 27.47, 112.50, 119.58, 127.29, 127.96,
128.60, 136.37, 154.50, 156.07, 164.19; ESIMS m/z 241 (M++1).
4. For the synthesis and biological activities of
a-pyrone moiety-containing
substances, see: (a) Oh, D.-C.; Gontang, E. A.; Kauffman, C. A.; Jensen, P. R.;
Fenical, W. J. Nat. Prod. 2008, 71, 570–575; (b) Trisuwan, K.; Rukachaisirikul, V.;
Sukpondma, Y.; Preedanon, S.; Phongpaichit, S.; Rungjindamai, N.; Sakayaroj, J. J.
Nat. Prod. 2008, 71, 1323–1326; (c) Aly, A. H.; Edrada-Ebel, R.; Wray, V.; Muller,
W. E. G.; Kozytska, S.; Hentschel, U.; Proksch, P.; Ebel, R. Phytochemistry 2008, 69,
1716–1725; (d) Cutignano, A.; Fontana, A.; Renzulli, L.; Cimino, G. J. Nat. Prod.
2003, 66, 1399–1401; (e) Sata, N.; Abinsay, H.; Yoshida, W. Y.; Horgen, F. D.;
Sitachitta, N.; Kelly, M.; Scheuer, P. J. J. Nat. Prod. 2005, 68, 1400–1403.
Compound 6f: 22%; colorless oil; IR (film) 1739, 1680, 1237, 1166 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 1.10–1.26 (m, 1H), 1.34–1.49 (m, 1H), 1.53–1.71 (m, 2H),
2.03–2.16 (m, 2H), 2.67–2.77 (m, 1H), 3.36 (dt, J = 12.9 and 2.7 Hz, 1H), 5.13 (dd,
J = 2.7 and 1.2 Hz, 1H), 5.49–5.52 (m, 1H), 6.56 (dd, J = 2.7 and 1.2 Hz, 1H), 7.13–
7.17 (m, 2H), 7.28–7.41 (m, 3H); 13C NMR (CDCl3, 75 MHz) d 20.96, 23.41, 28.31,
37.79, 50.22, 107.33, 127.53, 128.76, 128.94, 130.19, 138.74, 138.78, 150.03,
162.73; ESIMS m/z 241 (M++1).
Compound 8a: 98%; white solid, mp 159–162 °C; IR (KBr) 1736, 1219 cmÀ1 1H
;
5. For the synthesis of
a-pyrones and their derivatives from Baylis–Hillman
adducts, see: (a) Kim, S. J.; Lee, H. S.; Kim, J. N. Tetrahedron Lett. 2007, 48, 1069–
1072; (b) Kim, S. C.; Lee, H. S.; Kim, J. N. Bull. Korean Chem. Soc. 2007, 28, 147–
150; (c) Singh, V.; Madapa, S.; Batra, S. Synth. Commun. 2008, 38, 2113–2124; d
Zhong, W.; Su, W.; Zhao, Y. Faming Zhuanli Shenqing Gongkai Shuomingshu
2007, CN 10069825 (Chem. Abstr. 2008, 148, 121588).
NMR (CDCl3, 300 MHz) d 2.18 (s, 3H), 3.46 (s, 3H), 3.91 (s, 3H), 6.65–6.71 (m, 2H),
6.79–6.87 (m, 3H), 6.92–7.19 (m, 10H); 13C NMR (CDCl3, 75 MHz) d 18.28, 52.09,
52.56, 125.83, 126.58, 126.62, 126.69, 127.17, 127.71, 129.69, 129.84, 130.57,
131.41, 132.03, 133.94, 137.77, 138.63, 138.71, 139.38, 143.33, 144.46, 168.82,
168.97; ESIMS m/z 437 (M++1). Anal. Calcd for C29H24O4: C, 79.80; H, 5.54. Found:
C, 79.97; H, 5.78.
6. For the synthesis of poly-substituted aromatic compounds from a-pyrones by
Compound 8d: 94%; white solid, mp 174–175 °C; IR (KBr) 1736, 1221 cmÀ1 1H
;
Diels–Alder reaction, see: (a) Kuninobu, Y.; Takata, H.; Kawata, A.; Takai, K. Org.
Lett. 2008, 10, 3133–3135; (b) Kuninobu, Y.; Kawata, A.; Nishi, M.; Takata, H.;
Takai, K. Chem. Commun. 2008, 6360–6362; (c) Tolmachova, N. A.; Gerus, I. I.;
Vdovenko, S. I.; Essers, M.; Frohlich, R.; Haufe, G. Eur. J. Org. Chem. 2006, 4704–
4709; (d) Cho, C.-G.; Kim, Y.-W.; Lim, Y.-K.; Park, J.-S.; Lee, H.; Koo, S. J. Org.
Chem. 2002, 67, 290–293; (e) Komiyama, T.; Takaguchi, Y.; Tsuboi, S. Synth.
Commun. 2007, 37, 533–536; (f) Afarinkia, K.; Vinader, V.; Nelson, T. D.; Posner,
G. H. Tetrahedron 1992, 48, 9111–9171. and further references cited therein.
7. For the regioselective introduction of nucleophiles at the secondary positions of
Baylis–Hillman adducts by using the DABCO salt concept, see: (a) Kim, J. N.;
Kim, J. M.; Lee, K. Y.; Gowrisankar, S. Bull. Korean Chem. Soc. 2004, 25, 1733–
1736; (b) Gowrisankar, S.; Lee, H. S.; Kim, J. M.; Kim, J. N. Tetrahedron Lett. 2008,
49, 1670–1673.
8. The cinnamyl bromides were prepared by treatment of the Baylis–Hillman
alcohols with aqueous HBr according to the literature procedure, see: (a)
Buchholz, R.; Hoffmann, H. M. R. Helv. Chim. Acta 1991, 74, 1213–1220; (b)
Ameer, F.; Drewes, S. E.; Emslie, N. D.; Kaye, P. T.; Mann, R. L. J. Chem. Soc.,
Perkin Trans. 1 1983, 2293–2295.
9. Typical procedure for the synthesis of 3a, 4a, 7a, and 8a: A mixture of cinnamyl
bromide 1 (765 mg, 3.0 mmol) and DABCO (370 mg, 3.3 mmol) in CH3CN (5 mL)
was stirred for 30 min at room temperature (20–25 °C). To the reaction mixture
deoxybenzoin (2a, 706 mg, 3.6 mmol) and NaOH (144 mg, 3.6 mmol) were
added and stirred further for 24 h at room temperature (20–25 °C). After the
usual aqueous extractive workup and column chromatographic purification
process (hexanes/CH2Cl2/ether, 15:1:1) compound 3a was isolated as a white
solid, 866 mg (78%, syn/anti mixture). Compound 3a (740 mg, 2.0 mmol) was
dissolved in aqueous THF (H2O/THF, 1:1, 5 mL) and LiOH (420 mg, 10 mmol) was
added and the reaction mixture was heated to reflux for 24 h. After cooling to
room temperature, the reaction mixture was acidified with dilute HCl solution
NMR (CDCl3, 300 MHz) d 2.07 (s, 3H), 2.38–2.42 (m, 2H), 2.64–2.69 (m, 2H), 3.76
(s, 3H), 3.91 (s, 3H), 7.07–7.14 (m, 2H), 7.17–7.25 (m, 3H), 7.33–7.49 (m, 4H); 13C
NMR (CDCl3, 75 MHz) d 17.90, 27.71, 28.85, 52.46, 52.53, 126.38, 126.63, 127.37,
127.50, 127.83, 128.53, 128.76, 128.79, 131.71, 131.87, 132.98, 133.15, 138.48,
139.64, 140.23, 143.12, 169.34, 170.53; ESIMS m/z 387 (M++1). Anal. Calcd for
C25H22O4: C, 77.70; H, 5.74. Found: C, 77.89; H, 5.48.
Compound 9d: 93%; white solid, mp 67–69 °C; IR (KBr) 1736, 1282 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 2.21 (s, 3H), 3.97 (s, 3H), 3.98 (s, 3H), 7.20–7.25 (m, 3H), 7.43–
7.61 (m, 6H), 7.80–7.84 (m, 1H), 8.19–8.23 (m, 1H); 13C NMR (CDCl3, 75 MHz) d
18.06, 52.73, 52.92, 124.64, 125.58, 125.77, 126.27, 127.06, 127.60, 128.45,
128.57, 128.68, 128.72, 128.92, 129.74, 130.74, 132.27, 132.43, 132.70, 139.05,
142.27, 169.58, 171.47; ESIMS m/z 385 (M++1). Anal. Calcd for C25H20O4: C, 78.11;
H, 5.24. Found: C, 78.05; H, 5.49.
Compound 9h: 68%; colorless oil; IR (film) 1732, 1212 cmÀ1 1H NMR (CDCl3,
;
300 MHz) d 2.22 (s, 3H), 3.96 (s, 3H), 4.04 (s, 3H), 7.24–7.56 (m, 11H), 7.77 (dd,
J = 8.7 and 1.8 Hz, 1H), 8.27 (d, J = 8.7 Hz, 1H); 13C NMR (CDCl3, 75 MHz) d 18.39,
52.58, 52.76, 124.58, 126.23, 126.49, 127.30, 127.35, 127.64, 127.71, 128.71,
128.81 (2C), 129.74, 130.16, 132.22, 133.83, 138.70, 139.88, 140.45, 142.87,
168.22, 169.25; ESIMS m/z 411 (M++1). Anal. Calcd for C27H22O4: C, 79.01; H, 5.40.
Found: C, 79.33; H, 5.74.
10. For DBU-mediated isomerization, see: (a) Kim, K. H.; Lee, H. S.; Kim, J. N.
Tetrahedron Lett. 2009, 50, 1249–1251; (b) Kim, S. C.; Lee, H. S.; Lee, Y. J.; Kim, J.
N. Tetrahedron Lett. 2006, 47, 5681–5685; (c) Lee, M. J.; Lee, K. Y.; Gowrisankar,
S.; Kim, J. N. Tetrahedron Lett. 2006, 47, 1355–1358.
11. It is interesting to note that the phenyl group at 4-position of 7g and 7h showed
the presence of six carbon peaks in their 13C NMR spectrum, presumably due to
an asymmetry effect provided by the substituent at 6-position (–CH3 or phenyl).
The situation is same for the phenyl group of compounds 8g and 8h.